Childhood cerebellar tumours mirror conserved fetal transcriptional programs.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
08 2019
Historique:
received: 20 06 2018
accepted: 22 03 2019
pubmed: 3 5 2019
medline: 20 11 2019
entrez: 3 5 2019
Statut: ppublish

Résumé

Study of the origin and development of cerebellar tumours has been hampered by the complexity and heterogeneity of cerebellar cells that change over the course of development. Here we use single-cell transcriptomics to study more than 60,000 cells from the developing mouse cerebellum and show that different molecular subgroups of childhood cerebellar tumours mirror the transcription of cells from distinct, temporally restricted cerebellar lineages. The Sonic Hedgehog medulloblastoma subgroup transcriptionally mirrors the granule cell hierarchy as expected, while group 3 medulloblastoma resembles Nestin

Identifiants

pubmed: 31043743
doi: 10.1038/s41586-019-1158-7
pii: 10.1038/s41586-019-1158-7
pmc: PMC6675628
mid: NIHMS1525286
doi:

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

67-73

Subventions

Organisme : NIMH NIH HHS
ID : R37 MH085726
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH085726
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS092096
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA148699
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS106155
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA159859
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA192176
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Northcott, P. A. et al. Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 488, 49–56 (2012).
doi: 10.1038/nature11327
Mack, S. C. et al. Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling. Nature 553, 101–105 (2018).
doi: 10.1038/nature25169
Jones, D. T. et al. Dissecting the genomic complexity underlying medulloblastoma. Nature 488, 100–105 (2012).
doi: 10.1038/nature11284
Pugh, T. J. et al. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488, 106–110 (2012).
doi: 10.1038/nature11329
Northcott, P. A. et al. The whole-genome landscape of medulloblastoma subtypes. Nature 547, 311–317 (2017).
doi: 10.1038/nature22973
Jones, D. T. et al. Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat. Genet. 45, 927–932 (2013).
doi: 10.1038/ng.2682
Mack, S. C. et al. Epigenomic alterations define lethal CIMP-positive ependymomas of infancy. Nature 506, 445–450 (2014).
doi: 10.1038/nature13108
Cavalli, F. M. G. et al. Intertumoral heterogeneity within medulloblastoma subgroups. Cancer Cell 31, 737–754 (2017).
doi: 10.1016/j.ccell.2017.05.005
Dubuc, A. M., Mack, S., Unterberger, A., Northcott, P. A. & Taylor, M. D. The epigenetics of brain tumors. Methods Mol. Biol. 863, 139–153 (2012).
doi: 10.1007/978-1-61779-612-8_8
Dubuc, A. M. et al. Subgroup-specific alternative splicing in medulloblastoma. Acta Neuropathol. 123, 485–499 (2012).
doi: 10.1007/s00401-012-0959-7
Northcott, P. A. et al. Medulloblastoma comprises four distinct molecular variants. J. Clin. Oncol. 29, 1408–1414 (2011).
doi: 10.1200/JCO.2009.27.4324
Wechsler-Reya, R. J. & Scott, M. P. Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog. Neuron 22, 103–114 (1999).
doi: 10.1016/S0896-6273(00)80682-0
Wallace, V. A. Purkinje-cell-derived Sonic Hedgehog regulates granule neuron precursor cell proliferation in the developing mouse cerebellum. Curr. Biol. 9, 445–448 (1999).
doi: 10.1016/S0960-9822(99)80195-X
Li, P. et al. A population of Nestin-expressing progenitors in the cerebellum exhibits increased tumorigenicity. Nat. Neurosci. 16, 1737–1744 (2013).
doi: 10.1038/nn.3553
Kawauchi, D. et al. A mouse model of the most aggressive subgroup of human medulloblastoma. Cancer Cell 21, 168–180 (2012).
doi: 10.1016/j.ccr.2011.12.023
Pei, Y. et al. An animal model of MYC-driven medulloblastoma. Cancer Cell 21, 155–167 (2012).
doi: 10.1016/j.ccr.2011.12.021
Swartling, F. J. et al. Pleiotropic role for MYCN in medulloblastoma. Genes Dev. 24, 1059–1072 (2010).
doi: 10.1101/gad.1907510
Gibson, P. et al. Subtypes of medulloblastoma have distinct developmental origins. Nature 468, 1095–1099 (2010).
doi: 10.1038/nature09587
Vanner, R. J. et al. Quiescent Sox2
doi: 10.1016/j.ccr.2014.05.005
Pajtler, K. W. et al. The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants. Acta Neuropathol. 133, 5–12 (2017).
doi: 10.1007/s00401-016-1643-0
Pajtler, K. W. et al. Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 27, 728–743 (2015).
doi: 10.1016/j.ccell.2015.04.002
Witt, H. et al. Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell 20, 143–157 (2011).
doi: 10.1016/j.ccr.2011.07.007
Johnson, R. A. et al. Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 466, 632–636 (2010).
doi: 10.1038/nature09173
Taylor, M. D. et al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8, 323–335 (2005).
doi: 10.1016/j.ccr.2005.09.001
Pomeroy, S. L. et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415, 436–442 (2002).
doi: 10.1038/415436a
Capper, D. et al. DNA methylation-based classification of central nervous system tumours. Nature 555, 469–474 (2018).
doi: 10.1038/nature26000
Goldowitz, D. & Hamre, K. The cells and molecules that make a cerebellum. Trends Neurosci. 21, 375–382 (1998).
doi: 10.1016/S0166-2236(98)01313-7
Leto, K. et al. Consensus paper: cerebellar development. Cerebellum 15, 789–828 (2016).
doi: 10.1007/s12311-015-0724-2
Sillitoe, R. V. & Joyner, A. L. Morphology, molecular codes, and circuitry produce the three-dimensional complexity of the cerebellum. Annu. Rev. Cell Dev. Biol. 23, 549–577 (2007).
doi: 10.1146/annurev.cellbio.23.090506.123237
Fleming, J. T. et al. The Purkinje neuron acts as a central regulator of spatially and functionally distinct cerebellar precursors. Dev. Cell 27, 278–292 (2013).
doi: 10.1016/j.devcel.2013.10.008
Parmigiani, E. et al. Heterogeneity and bipotency of astroglial-like cerebellar progenitors along the interneuron and glial lineages. J. Neurosci. 35, 7388–7402 (2015).
doi: 10.1523/JNEUROSCI.5255-14.2015
Wojcinski, A. et al. Cerebellar granule cell replenishment postinjury by adaptive reprogramming of Nestin
doi: 10.1038/nn.4621
Saunders, A. et al. Molecular diversity and specialization among the cells of the adult mouse brain. Cell 174, 1015–1030 (2018).
doi: 10.1016/j.cell.2018.07.028
Zeisel, A. et al. Molecular architecture of the mouse nervous system. Cell 174, 999–1014 (2018).
doi: 10.1016/j.cell.2018.06.021
Yeung, J. & Goldowitz, D. Wls expression in the rhombic lip orchestrates the embryonic development of the mouse cerebellum. Neuroscience 354, 30–42 (2017).
doi: 10.1016/j.neuroscience.2017.04.020
Yeung, J. et al. Wls provides a new compartmental view of the rhombic lip in mouse cerebellar development. J. Neurosci. 34, 12527–12537 (2014).
doi: 10.1523/JNEUROSCI.1330-14.2014
Garzia, L. et al. A hematogenous route for medulloblastoma leptomeningeal metastases. Cell 173, 1549 (2018).
doi: 10.1016/j.cell.2018.05.033
Morrissy, A. S. et al. Spatial heterogeneity in medulloblastoma. Nat. Genet. 49, 780–788 (2017).
doi: 10.1038/ng.3838
Morrissy, A. S. et al. Divergent clonal selection dominates medulloblastoma at recurrence. Nature 529, 351–357 (2016).
doi: 10.1038/nature16478
Wu, X. et al. Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature 482, 529–533 (2012).
doi: 10.1038/nature10825
Tan, I. L. et al. Lateral cerebellum is preferentially sensitive to high Sonic Hedgehog signaling and medulloblastoma formation. Proc. Natl Acad. Sci. USA 115, 3392–3397 (2018).
doi: 10.1073/pnas.1717815115
Kim, J. A., Sekerková, G., Mugnaini, E. & Martina, M. Electrophysiological, morphological, and topological properties of two histochemically distinct subpopulations of cerebellar unipolar brush cells. Cerebellum 11, 1012–1025 (2012).
doi: 10.1007/s12311-012-0380-8
Nguyen, Q. H. et al. Profiling human breast epithelial cells using single cell RNA sequencing identifies cell diversity. Nat. Commun. 9, 2028 (2018).
doi: 10.1038/s41467-018-04334-1
De Simoni, A. & Yu, L. M. Preparation of organotypic hippocampal slice cultures: interface method. Nat. Protocols 1, 1439–1445 (2006).
doi: 10.1038/nprot.2006.228
Zheng, G. X. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).
doi: 10.1038/ncomms14049
Lun, A. T. L., Bach, K. & Marioni, J. C. Pooling across cells to normalize single-cell RNA sequencing data with many zero counts. Genome Biol. 17, 75 (2016).
doi: 10.1186/s13059-016-0947-7
Zerbino, D. R. et al. Ensembl 2018. Nucleic Acids Res. 46, D754–D761 (2018).
doi: 10.1093/nar/gkx1098
Satija, R., Farrell, J. A., Gennert, D., Schier, A. F. & Regev, A. Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol. 33, 495–502 (2015).
doi: 10.1038/nbt.3192
Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411–420 (2018).
doi: 10.1038/nbt.4096
Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381–386 (2014).
doi: 10.1038/nbt.2859
Qiu, X. et al. Reversed graph embedding resolves complex single-cell trajectories. Nat. Methods 14, 979–982 (2017).
doi: 10.1038/nmeth.4402
Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453–457 (2015).
doi: 10.1038/nmeth.3337
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
doi: 10.1093/bioinformatics/bts635
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
doi: 10.1186/s13059-014-0550-8
Whitfield, M. L. et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol. Biol. Cell. 6, 1977–2000 (2002).
doi: 10.1091/mbc.02-02-0030

Auteurs

Maria C Vladoiu (MC)

Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

Ibrahim El-Hamamy (I)

Computational Biology Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.

Laura K Donovan (LK)

Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.

Hamza Farooq (H)

Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

Borja L Holgado (BL)

Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.

Yogi Sundaravadanam (Y)

Computational Biology Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.

Vijay Ramaswamy (V)

Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.
Division of Haematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.

Liam D Hendrikse (LD)

Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.

Sachin Kumar (S)

Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

Stephen C Mack (SC)

Brain Tumor Program, Children's Cancer Center and Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.

John J Y Lee (JJY)

Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

Vernon Fong (V)

Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.

Kyle Juraschka (K)

Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

David Przelicki (D)

Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

Antony Michealraj (A)

Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.

Patryk Skowron (P)

Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

Betty Luu (B)

Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.

Hiromichi Suzuki (H)

Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.

A Sorana Morrissy (AS)

Department of Biochemistry & Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Florence M G Cavalli (FMG)

Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.

Livia Garzia (L)

Cancer Research Program, McGill University Health Centre Research Institute, Montreal, Quebec, Canada.

Craig Daniels (C)

Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.

Xiaochong Wu (X)

Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.

Maleeha A Qazi (MA)

Stem Cell and Cancer Research Institute, McMaster University, Hamilton, Ontario, Canada.
Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.

Sheila K Singh (SK)

Stem Cell and Cancer Research Institute, McMaster University, Hamilton, Ontario, Canada.
Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.
Department of Surgery, McMaster University, Hamilton, Ontario, Canada.

Jennifer A Chan (JA)

Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.

Marco A Marra (MA)

Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada.
Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.

David Malkin (D)

Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.

Peter Dirks (P)

Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
Division of Neurosurgery, The Hospital for Sick Children, Toronto, Ontario, Canada.

Lawrence Heisler (L)

Computational Biology Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.

Trevor Pugh (T)

Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Ontario Institute for Cancer Research, Toronto, Ontario, Canada.

Karen Ng (K)

Ontario Institute for Cancer Research, Toronto, Ontario, Canada.

Faiyaz Notta (F)

Ontario Institute for Cancer Research, Toronto, Ontario, Canada.

Eric M Thompson (EM)

Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.

Claudia L Kleinman (CL)

Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
Lady Davis Research Institute, Jewish General Hospital, Montreal, Quebec, Canada.

Alexandra L Joyner (AL)

Developmental Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

Nada Jabado (N)

Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada. nada.jabado@mcgill.ca.

Lincoln Stein (L)

Computational Biology Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada. lincoln.stein@oicr.on.ca.

Michael D Taylor (MD)

Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada. mdt.cns@gmail.com.
The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada. mdt.cns@gmail.com.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. mdt.cns@gmail.com.
Division of Neurosurgery, The Hospital for Sick Children, Toronto, Ontario, Canada. mdt.cns@gmail.com.
Department of Surgery and Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. mdt.cns@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH